Gofen & Glossberg’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $920K | Sell |
8,318
-570
| -6% | -$59.7K | 0.02% | 251 |
|
|
2022
Q3 | $776K | Sell |
8,888
-36
| -0.4% | -$3.27K | 0.02% | 255 |
|
|
2022
Q2 | $698K | Hold |
8,924
| – | – | 0.02% | 269 |
|
|
2022
Q1 | $761K | Hold |
8,924
| – | – | 0.02% | 273 |
|
|
2021
Q4 | $1.07M | Hold |
8,924
| – | – | 0.02% | 239 |
|
|
2021
Q3 | $1.1M | Buy |
8,924
+2,118
| +31% | +$273K | 0.03% | 236 |
|
|
2021
Q2 | $816K | Hold |
6,806
| – | – | 0.02% | 266 |
|
|
2021
Q1 | $716K | Buy |
6,806
+3,500
| +106% | +$355K | 0.02% | 277 |
|
|
2020
Q4 | $337K | Buy |
3,306
+356
| +12% | +$33.5K | 0.01% | 374 |
|
|
2020
Q3 | $248K | Buy |
+2,950
| New | +$230K | 0.01% | 402 |
|
|
2020
Q1 | – | Sell |
-2,634
| Closed | -$208K | – | 475 |
|
|
2019
Q4 | $208K | Hold |
2,634
| – | – | 0.01% | 439 |
|
|
2019
Q3 | $210K | Hold |
2,634
| – | – | 0.01% | 424 |
|
|
2019
Q2 | $220K | Hold |
2,634
| – | – | 0.01% | 403 |
|
|
2019
Q1 | $208K | Buy |
+2,634
| New | +$192K | 0.01% | 411 |
|
|
2018
Q4 | – | Sell |
-2,634
| Closed | -$210K | – | 453 |
|
|
2018
Q3 | $210K | Buy |
+2,634
| New | +$197K | 0.01% | 427 |
|
|
2018
Q2 | – | Sell |
-2,634
| Closed | -$203K | – | 458 |
|
|
2018
Q1 | $203K | Sell |
2,634
-2,515
| -49% | -$186K | 0.01% | 427 |
|
|
2017
Q4 | $351K | Sell |
5,149
-2,800
| -35% | -$186K | 0.01% | 358 |
|
|
2017
Q3 | $498K | Hold |
7,949
| – | – | 0.02% | 290 |
|
|
2017
Q2 | $441K | Hold |
7,949
| – | – | 0.02% | 307 |
|
|
2017
Q1 | $399K | Hold |
7,949
| – | – | 0.02% | 322 |
|
|
2016
Q4 | $394K | Hold |
7,949
| – | – | 0.02% | 306 |
|
|
2016
Q3 | $417K | Sell |
7,949
-4
| -0.1% | -$196 | 0.02% | 299 |
|
|
2016
Q2 | $355K | Sell |
7,953
-34
| -0.4% | -$1.48K | 0.01% | 321 |
|
|
2016
Q1 | $327K | Buy |
7,987
+38
| +0.5% | +$1.4K | 0.01% | 329 |
|
|
2015
Q4 | $290K | Hold |
7,949
| – | – | 0.01% | 350 |
|
|
2015
Q3 | $261K | Buy |
7,949
+1,600
| +25% | +$53.8K | 0.01% | 369 |
|
|
2015
Q2 | $235K | Sell |
6,349
-445
| -7% | -$16.2K | 0.01% | 406 |
|
|
2015
Q1 | $238K | Sell |
6,794
-400
| -6% | -$14.1K | 0.01% | 405 |
|
|
2014
Q4 | $274K | Hold |
7,194
| – | – | 0.01% | 377 |
|
|
2014
Q3 | $255K | Hold |
7,194
| – | – | 0.01% | 377 |
|
|
2014
Q2 | $281K | Sell |
7,194
-155
| -2% | -$5.79K | 0.01% | 363 |
|
|
2014
Q1 | $289K | Buy |
7,349
+400
| +6% | +$14.6K | 0.01% | 344 |
|
|
2013
Q4 | $240K | Buy |
+6,949
| New | +$224K | 0.01% | 376 |
|
Other funds holding XYL
PAMS
Gofen & Glossberg's XYL Position: Q4 2022 in Review
Gofen & Glossberg reduced its Xylem (XYL) stake by 6.4% in Q4 2022, selling an estimated $59.7K and leaving 8,318 shares worth $920K. The position accounts for 0.02% of the portfolio, ranked #251.
Gofen & Glossberg first reported a position in XYL in Q4 2013 and has held it in 33 quarters since. The position peaked at $1.1M in Q3 2021. 819 funds tracked by Wall St. Rank hold XYL as of Q4 2022.
- Gofen & Glossberg held 8,318 shares of Xylem worth $920K as of Q4 2022.
- Gofen & Glossberg sold 570 Xylem shares in Q4 2022, an estimated $59.7K.
- Xylem made up 0.02% of Gofen & Glossberg's portfolio in Q4 2022, its #251 holding.
- Gofen & Glossberg first reported a position in Xylem in Q4 2013 and has held it in 33 quarters since.
- Gofen & Glossberg's Xylem position peaked at $1.1M in Q3 2021.
- 819 funds tracked by Wall St. Rank held Xylem as of Q4 2022.
Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.